Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission - Top-Institutions - MDSpire

Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission

  • By

  • Manuela Schoeb

  • Paula J C Sintenie

  • Leontine E H Bakker

  • Nienke R Biermasz

  • Femke M van Haalen

  • Michiel F Nijhoff

  • Friso de Vries

  • Elizabeth M Winter

  • Alberto M Pereira

  • Natasha M Appelman-Dijkstra

  • November 20, 2024

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Metabolic Bone Disease
    • Osteoporosis Research

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Bone Metabolism
    • Clinical Research

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Osteoporosis
    • Bone Quality Research

  • #4

    University of Cambridge, Metabolic Bone Centre
    University of Cambridge, Metabolic Bone Centre

    Cambridge, UK

    Key Differentiators

    • Metabolic Bone Disease
    • Endocrinology
    • Bone Quality

  • #5

    University of Michigan, Bone and Mineral Disorders Program
    University of Michigan, Bone and Mineral Disorders Program

    Ann Arbor, MI

    Key Differentiators

    • Endocrinology
    • Bone Metabolism
    • Osteoporosis

Original Source(s)

Bone Material Strength Index Is Low in Patients With Cushing's Syndrome Even After Long-term Remission

  • by Manuela Schoeb, Paula J C Sintenie, Leontine E H Bakker, Nienke R Biermasz, Femke M van Haalen, Michiel F Nijhoff, Friso de Vries, Elizabeth M Winter, Alberto M Pereira, Natasha M Appelman-Dijkstra

  • November 20, 2024

Related Content

Uridine Suppresses ROS-Driven Osteoclast Differentiation and Mitigates Osteoporosis Through PI3K/Akt–FoxO Pathway Modulation

Cable-Plate augmentation improves the therapeutic effect of intramedullary nailing for AO/OTA type A2.3 intertrochanteric fractures with large coronal fragments: a double-center retrospective study

The endocrine pathway during whole body vibration modulates the immune system and the osteogenesis in postmenopausal women with osteoporosis